NAMPT protects against 6-hydroxydopamine-induced neurotoxicity in PC12 cells through modulating SIRT1 activity

Molecular Medicine Reports

Volumn 13, Issue 5, 2016, Pages 4058-4064

  Zou, Xiao Dong ^a   Guo, Shao Qing ^b   Hu, Zhi Wei ^a   Li, Wei Lang ^a  

^a Tongde Hospital of Zhejiang Province   (China)

^b Zhejiang Academy of Traditional Chinese Medicine   (China)

Author keywords

6 hydroxydopamine; Nicotinamide adenine dinucleotide; Nicotinamide phosphoribosyltransferase; PC12 cells; Sirtuin 1

Indexed keywords

LACTATE DEHYDROGENASE; MALONALDEHYDE; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE NUCLEOTIDE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OXIDOPAMINE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; SIRTUIN 1; SUPEROXIDE DISMUTASE; ACRYLAMIDE DERIVATIVE; CYTOKINE; N-(4-(1-BENZOYLPIPERIDIN-4-YL)BUTYL)-3-(PYRIDIN-3-YL)ACRYLAMIDE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE, RAT; PIPERIDINE DERIVATIVE; SIRT1 PROTEIN, RAT;

ANIMAL CELL; ARTICLE; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; IN VITRO STUDY; LIPID OXIDATION; MTT ASSAY; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PC12 CELL LINE; RAT; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL SURVIVAL; CHEMICALLY INDUCED; DRUG EFFECTS; ENZYMOLOGY; METABOLISM; PARKINSON DISEASE, SECONDARY;

ACRYLAMIDES; ANIMALS; CELL SURVIVAL; CYTOKINES; L-LACTATE DEHYDROGENASE; MALONDIALDEHYDE; NICOTINAMIDE MONONUCLEOTIDE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OXIDOPAMINE; PARKINSON DISEASE, SECONDARY; PC12 CELLS; PIPERIDINES; RATS; SIRTUIN 1;

EID: 84964735364     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2016.5034     Document Type: Article

References (34)

1. Beal MF: Experimental models of Parkinson's disease. Nat Rev Neurosci 2:325-334, 2001.
2. Hanrott K, Gudmunsen L, O'Neill MJ and Wonnacott S: 6-hydroxydopamine-induced apoptosis is mediated via extracellular auto-oxidation and caspase 3-dependent activation of protein kinase Cdelta. J Biol Chem 281:5373-5382, 2006.
3. Blandini F, Armentero MT and Martignoni E: The 6-hydroxydopamine model: News from the past. Parkinsonism Relat Disord 14(Suppl 2):S124-S129, 2008.
4. Surendran S and Rajasankar S: Parkinson's disease: Oxidative stress and therapeutic approaches. Neurol Sci 31:531-540, 2010.
5. Soto-Otero R, Méndez-Alvarez E, Hermida-Ameijeiras A, Muñoz-Patiño AM and Labandeira-Garcia JL: Autoxidation and neurotoxicity of 6-hydroxydopamine in the presence of some antioxidants. J Neurochem 74:1605-1612, 2000.
6. Han XH, Cheng MN, Chen L, Fang H, Wang LJ, Li XT and Qu ZQ: 7, 8-dihydroxyflavone protects PC12 cells against 6-hydroxydopamine-induced cell death through modulating PI3K/Akt and JNK pathways. Neurosci Lett 581:85-88, 2014.
7. Xu DP, Zhang K, Zhang ZJ, Sun YW, Guo BJ, Wang YQ, Hoi PM, Han YF and Lee SM: A novel tetramethylpyrazine bis-nitrone (TN-2) protects against 6-hydroxyldopamine-induced neurotoxicity via modulation of the NF-κb and the PKCa/PI3-K/Akt pathways. Neurochem Int 78:76-85, 2014.
8. Wang L, Wang R, Jin M, Huang Y, Liu A, Qin J, Chen M, Wen S, Pi R and Shen W: Carvedilol attenuates 6-hydroxydopamine-induced cell death in PC12 Cells: Involvement of Akt and Nrf2/ARE pathways. Neurochem Res 39:1733-1740, 2014.
9. Imai SI, Armstrong CM, Kaeberlein M and Guarente L: Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 403:795-800, 2000.
10. Rongvaux A, Shea RJ, Mulks MH, Gigot D, Urbain J, Leo O and Andris F: Pre-B-cell colony-enhancing factor, whose expression is up-regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis. Eur J Immunol 32:3225-3234, 2002.
11. Revollo JR, Grimm AA and Imai S: The regulation of nicotinamide adenine dinucleotide biosynthesis by Nampt/PBEF/visfatin in mammals. Curr Opin Gastroenterol 23:164-170, 2007.
12. Revollo JR, Grimm AA and Imai S: The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells. J Biol Chem 279:50754-50763, 2004.
13. Ying W: NAD+/NADH and NADP+/NADPH in cellular functions and cell death: Regulation and biological consequences. Antioxid Redox Signal 10:179-206, 2008.
14. 2 accelerates cellular senescence by accumulation of acetylated p53 via decrease in the function of SIRT1 by NAD+ depletion. Cell Physiol Biochem 20:45-54, 2007.
15. Lu L, Tang L, Wei W, Hong Y, Chen H, Ying W and Chen S: Nicotinamide mononucleotide improves energy activity and survival rate in an in vitro model of Parkinson's disease. Exp Ther Med 8:943-950, 2014.
16. Milne JC, Lambert PD, Schenk S, Carney DP, Smith JJ, Gagne DJ, Jin L, Boss O, Perni RB, Vu CB, et al: Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature 450:712-716, 2007.
17. Araki T, Sasaki Y and Milbrandt J: Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration. Science 305:1010-1013, 2004.
18. Tanno M, Kuno A, Yano T, Miura T, Hisahara S, Ishikawa S, Shimamoto K and Horio Y: Induction of manganese superoxide dismutase by nuclear translocation and activation of SIRT1 promotes cell survival in chronic heart failure. J Biol Chem 285:8375-8382, 2010.
19. Liu T, Liu PY and Marshall GM: The critical role of the class III histone deacetylase SIRT1 in cancer. Cancer Res 69:1702-1705, 2009.
20. Cohen HY, Miller C, Bitterman KJ, Wall NR, Hekking B, Kessler B, Howitz KT, Gorospe M, de Cabo R and Sinclair DA: Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science 305:390-392, 2004.
21. Salminen A, Huuskonen J, Ojala J, Kauppinen A, Kaarniranta K and Suuronen T: Activation of innate immunity system during aging: NF-κB signaling is the molecular culprit of inflamm-aging. Ageing Res Rev 7:83-105, 2008.
22. Chen WY, Wang DH, Yen RC, Luo J, Gu W and Baylin SB: Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses. Cell 123:437-448, 2005.
23. Hasegawa K, Wakino S, Yoshioka K, Tatematsu S, Hara Y, Minakuchi H, Washida N, Tokuyama H, Hayashi K and Itoh H: Sirt1 protects against oxidative stress-induced renal tubular cell apoptosis by the bidirectional regulation of catalase expression. Biochem Biophys Res Commun 372:51-56, 2008.
24. Jeong J, Juhn K, Lee H, Kim SH, Min BH, Lee KM, Cho MH, Park GH and Lee KH: SIRT1 promotes DNA repair activity and deacetylation of Ku70. Exp Mol Med 39:8-13, 2007.
25. Bu Q, Yang Y, Yan G, Hu Z, Hu C, Duan J, Lv L, Zhou J, Zhao J, Shao X, et al: Proteomic analysis of the nucleus accumbens in rhesus monkeys of morphine dependence and withdrawal intervention. J Proteomics 75:1330-1342, 2012.
26. Zhao X, Zhai S, An MS, Wang YH, Yang YF, Ge HQ, Liu JH and Pu XP: Neuroprotective effects of protocatechuic aldehyde against neurotoxin-induced cellular and animal models of Parkinson's disease. PloS One 8:e78220, 2013.
27. Blum D, Torch S, Lambeng N, Nissou M, Benabid AL, Sadoul R and Verna JM: Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: Contribution to the apoptotic theory in Parkinson's disease. Prog Neurobiol 65:135-172, 2001.
28. Schober A: Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP. Cell Tissue Res 318:215-224, 2004.
29. Saito Y, Nishio K, Ogawa Y, Kinumi T, Yoshida Y, Masuo Y and Niki E: Molecular mechanisms of 6-hydroxydopamine-induced cytotoxicity in PC12 cells: Involvement of hydrogen peroxide-dependent and-independent action. Free Radic Biol Med 42:675-685, 2007.
30. Fujita H, Ogino T, Kobuchi H, Fujiwara T, Yano H, Akiyama J, Utsumi K and Sasaki J: Cell-permeable cAMP analog suppresses 6-hydroxydopamine-induced apoptosis in PC12 cells through the activation of the Akt pathway. Brain Res 1113:10-23, 2006.
31. Yang T and Sauve AA: NAD metabolism and sirtuins: Metabolic regulation of protein deacetylation in stress and toxicity. AAPS J 8:E632-E643, 2006.
32. Bürkle A: Poly (ADP-ribose). The most elaborate metabolite of NAD+. FEBS J 272:4576-4589, 2005.
33. Halliwell B: Oxidative stress and neurodegeneration: Where are we now? J Neurochem 97:1634-1658, 2006.
34. Zhang T and Kraus WL: SIRT1-dependent regulation of chromatin and transcription: Linking NAD metabolism and signaling to the control of cellular functions. Biochim Biophys Acta 1804:1666-1675, 2010.